Clinical Trials Browser

Completed × Observational × Pancreatic Cancer Resectable × Clear all

NCT06809374 2025-02-05

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Gastrointestinal

Pancreatic Cancer Resectable